Lanzhou Foci Pharmaceutical Co.,Ltd.



Quote for Lanzhou Foci Pharmaceutical Co.,Ltd.

Last Trade:
-
Change:
--
Symbol/Code:
002644
Status:
-
Stock Type:
A Share
Market Cap:
-
Open:
-
Prev Close:
-
Bid:
-
Ask:
-
Volume(*100):
-
Amount:
-
Limit Up:
-
Limit Down:
-
Day's Range:
-
P/E(ttm):
-
P/B ratio
-
Update:-
Currency in CNY Time=UTC+8002644 quote

Summary for Lanzhou Foci Pharmaceutical Co.,Ltd.

Lanzhou Foci Pharmaceutical Co., Ltd. is principally engaged in the research, development, manufacture and distribution of Chinese patent medicines. The Company provides pills, tablets, granules, capsules, powders, oral liquid, syrup and vinum, among others. Its products are 191 over the counter (OTC) and 271 receptor medicines, including Liuwei Dihuang Pills, Xiaoyao Pills, Guifu Dihuang Pills, Zhibai Dihuang Pills, Shenrong Guben Huanshao Pills, Xiangsha Yangwei Pills, Lycii and Chrysanthemi and Rehmanniae Bolus, Buzhong Yiqi Pills, Spleen-tonyfying Pills, Tianwang Buxin Pills, Mingmu Diuang Pills, Ercong Zuoci Pills, Baohe Pills, Giant-hyssop Pills, Anshen Buxin Pills, Danggui Pills and Jianpi Pills, among others.

Profile for Lanzhou Foci Pharmaceutical Co.,Ltd.

Full Name:Lanzhou Foci Pharmaceutical Co.,Ltd.
Full Name in Chinese:兰州佛慈制药股份有限公司 Short Name in Chinese:佛慈制药
Symbol/Stock Code:
002644
Listed in:
Shenzhen Stock Exchange
Issued Capital
-
Negotiable Capital:
-
Chairman:
Jia Chaomin
Secretary of the Board:
Sun Yu
Phone:
+86-931-8362318
Fax:
+86-931-8368945
Official Website:www.fczy.com
E-mail:zqb@fczy.com
Address:68 Foci Road,Chengguan District,LANZHOU 730046
IPO Subscription Date:
2011-12-13
Listing Date:
2011-12-22
IPO Issued Capital:
20200000
IPO Price:
16 CNY
IPO fees:
33639300 CNY
Money Raised by IPO:
323200000 CNY
IPO Par Value:
1.00 CNY
Net Money Raised:
289560700 CNY
Open(Listing day):
17.22 CNY
Close(Listing day):
19.23 CNY
Diluted P/E ratio after IPO:
46.9200
Turnover rate(listing day):
90.07%

Financials for Lanzhou Foci Pharmaceutical Co.,Ltd.

UPDATE:2012-10-28 Annual Report Abstract:(All Currency In CNY)

Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Net Profit(after tax)(Million)
20.2435
32.0607
51.2417
36.1468
Net Profit Growth(%)
-17.95
-37.43
41.75
67.27
Return On Equity(ROE)(%)
3.04
4.95
15.70
14.29
Debt ratio(%)
15.14
21.84
28.43
40.06
Net Operating Cash Flow/Net Profit(%)
-202.85
7.57
109.64
9.59

Per Share Financial Data:(All Currency In CNY)

Per Share Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Earnings Per Share(EPS)
0.2300
0.5300
0.8500
0.6000
Diluted Earnings Per Share
0.0000
0.4600
0.4500
0.4000
Net Asset Value Per Share (NAVPS)
7.4900
8.0200
5.3900
4.1800
Additional Paid-In Capital Per Share
3.2819
3.6101
0.3675
0.0000
Retained Earnings Per Share
2.7269
2.8850
3.3707
2.6094
Net Cash Flow From Operatings Activities Per Share
-0.4600
0.0300
0.9300
0.0600
Net Cash Flow Per Share
-1.6219
3.1899
0.8097
0.1565

Balance Sheet:(All Currency In CNY)

Assets And Liabilities/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Total Assets(Million)
784.1908
829.2286
456.1618
422.0499
Total Liabilities(Million)
118.7713
181.1444
129.699
169.0903
Current Liabilities(Million)
105.7209
167.5456
116.2985
158.0626
Long Term Liabilities(Million)
-
-
-
-
Cash And Cash Equivalents(Million)
181.3515
325.4702
67.7939
18.7443
Accounts Receivables(Million)
121.2144
69.5178
62.0867
88.175
Deposit Received(Million)
1.397
3.6668
3.4787
11.5781
Other Receivables(Million)
5.6906
6.1144
3.8404
7.7683
Bad Debt Reserve(Million)
-
-
-
-
Shareholder's Equity/Owner's Equity(Million)
665.4196
648.0842
326.4628
252.9595
Debt ratio(%)
15.14
21.84
28.43
40.06
Equity Ratio(%)
84.8500
78.1500
71.5600
59.9300
Current Ratio
4.2039
3.3334
1.9559
1.3104
Quick Ratio
3.0458
2.4992
1.2175
0.8049

Cash Flow Statement:(All Currency In CNY)

Cash Flow/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Cash From Selling Commodities(Million)
182.179
260.7347
294.4325
247.6312
Net Cash Flow From Operatings Activities(Million)
-41.0635
2.426
56.1793
3.4648
Net Cash Flow From Operatings Activities Change(%)
-318.32
-95.68
1521.42
475.01
Net Cash Flow(Million)
-144.1187
257.6764
49.0496
9.4801
Cash From Selling Commodities/Prime Revenue(%)
85.24
96.15
112.20
106.64
Net Cash Flow/Net Profit(%)
-711.93
803.72
95.72
26.23
Cash Flow From Investing Activities(Million)
-91.48
-69.8984
-6.0016
23.3374
Cash Flow From Financing Activities(Million)
-11.5853
325.2591
-0.9978
-17.2891

Income Statement:(All Currency In CNY)

Income Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Prime Operating Revenue(Million)
213.728
271.1843
262.406
232.2093
Prime Operating Profit(Million)
-
-
-
-
Operating Costs(Million)
20.6812
31.0368
35.2759
34.8871
Administrative Costs(Million)
20.9525
22.4097
19.0426
18.5526
Financing Costs(Million)
1.5718
4.6073
3.6081
2.5635
Above Three Costs Change(%)
-19.44
0.22
3.43
-4.34
Operating Profit(Million)
20.1958
31.5321
31.6638
27.0671
Income From Investment(Million)
-
-
-
-
Government Subsidies(Million)
-
-
-
-
Net Non-Operating Income And Expense(Million)
3.195
4.7584
24.0451
13.538
Total Profit(Million)
23.3908
36.2905
55.7089
40.6051
Corporate Income Tax(Million)
3.1473
4.2299
4.4672
4.4582
Net Profit(Million)
20.2435
32.0607
51.2417
36.1468
Gross Profit Ratio(%)
31.52
34.36
36.17
37.91
Operating Margin(%)
9.44
11.62
12.06
11.65
Return On Equity(ROE)(%)
3.04
4.95
15.70
14.29

Announcements for Lanzhou Foci Pharmaceutical Co.,Ltd.

Date: 2012-09-14
Title: EGM RESOLUTION
The Company held its 1st Extraordinary General Meeting of 2012 on 13 September 2012, during which the following proposal(s) was/were approved:
1. Rules for accumulative voting system
2. Online voting rules for the general meeting of shareholders
3. Investment decision-making management measures
4. Shareholder return plan for the next three years from 2012 to 2014
5. Amendments to terms concerning profit distribution decision-making procedures and mechanism in the Company's articles of association
6. To entrust a company to handle matters regarding equity transfer
Date: 2012-08-29
Title: EGM-SPOT
The Company will hold the 1st Extraordinary General Meeting of 2012 at 09:30 on 13 September 2012.

Meeting agenda:
1. Rules for accumulative voting system
2. Online voting rules for the general meeting of shareholders
3. Investment decision-making management measures
4. Shareholder return plan for the next three years from 2012 to 2014
5. Amendments to terms concerning profit distribution decision-making procedures and mechanism in the Company's articles of association
6. To entrust a company to handle matters regarding equity transfer


Meeting attendees:
1. A-share holders registered at CSDCC Shenzhen after the close of trading on 07 September 2012 are entitled to vote. Original notarized power of attorney for voting is required.
2. Directors of the board, supervisors of the supervisory committee, senior executives and appointed lawyers are entitled to attend the meeting.

Registration period: from 10 September 2012 to 10 September 2012
Date: 2012-05-30
Title: DIVIDEND IMPLEMENTATION (CASH AND STOCK DIVIDEND)
2011 final distribution plan to be implemented (A shares):

1. Cash dividend/10 shares (tax included): CNY0.36000000
2. Bonus issue from profit (share/10 shares): 1.0000
3. Bonus issue from capital reserve (share/10 shares): none



Record date: 05 June 2012
Ex-date: 06 June 2012
Payment date: 06 June 2012
Listing date of the bonus issues: 06 June 2012

10 percent withholding tax on cash dividend and bonus shares from profit will be deducted in CNY within the cash dividend receivable. Please refer to below details:
Tax on cash dividend/10 shares: CNY0.03600000(10 percent x CNY0.36000000)

Tax on bonus shares from profit/10 shares: CNY0.10000000(10pct x CNY1(par value of the bonus shares) x 1.0000)
Total tax amount/10 shares: CNY0.13600000 (CNY0.03600000 plus CNY0.10000000)
Net amount after tax/10 shares: CNY0.22400000(CNY0.36000000- CNY0.13600000).
Date: 2012-05-09
Title: AGM RESOLUTION
The Company held its Annual General Meeting of 2011 on 08 May 2012, during which the following proposal(s) was/were approved:
1. 2011 work report of the board of directors
2. 2011 work report of the supervisory committee
3. 2011 financial resolution report
4. 2011 profit distribution plan
5. 2011 annual report and its summary
6. Appointment of audit firm
7. Self-appraisal report on internal control
8. Special report on the deposit and use of raised funds
9. Expansion of the Company's business scope
10. Amendments to the Company's articles of association
11. Amendments to the Company's management system on internal audit
The detailed profit distribution plan are as follows:
1) Cash dividend/10 shares (tax included): CNY0.36000000
2) Bonus issue from profit (share/10 shares): 1.00
3) Bonus issue from capital reserve (share/10 shares): none.
Date: 2012-04-10
Title: FINAL DIVIDEND
The Company issued its 2011 annual report on 10 April 2012.

The profit distribution proposal for 2011:
1. Cash dividend/10 shares (tax included): CNY0.36000000
2. Bonus issue from profit (share/10 shares):1.0000
3. Bonus issue from capital reserve (share/10 shares):none.
Date: 2012-04-10
Title: AGM-SPOT
The Company will hold the 2011 Annual General Meeting at 09:30 on 08 May 2012.

Meeting agenda:
1. 2011 work report of the board of directors
2. 2011 work report of the supervisory committee
3. 2011 financial resolution report
4. 2011 profit distribution plan
5. 2011 annual report and its summary
6. Appointment of audit firm
7. Self-appraisal report on internal control
8. Special report on the deposit and use of raised funds
9. Expansion of the Company's business scope
10. Amendments to the Company's articles of association
11. Amendments to the Company's management system on internal audit
The detailed profit distribution plan are as follows:
1) Cash dividend/10 shares (tax included): CNY0.36000000
2) Bonus issue from profit (share/10 shares): 1.0000
3) Bonus issue from capital reserve (share/10 shares): none

Meeting attendees:
1. A-share holders registered at CSDCC Shenzhen after the close of trading on 02 May 2012 are entitled to vote. Original notarized power of attorney for voting is required.
2. Directors of the board, supervisors of the supervisory committee, senior executives and appointed lawyers are entitled to attend the meeting.

Registration period: 04 May 2012
Date: 2012-03-19
Title: PLACING SHARE LISTING
The Company's 3.9 million A-shares placed to the institutional investors through offline placement will reach the 3-month lock-up period and be listed on the Shenzhen Stock Exchange as of 22 March 2012.
Date: 2011-12-21
Title: IPO SHARE LISTING
The Company issued a total of 20.2 million shares (code:002644) in its initial public offering. Of the shares,16.3 million shares will be listed on the Shenzhen Stock Exchange on 22 December 2011 while the remainder will become tradable three months later.
Date: 2011-12-12
Title: IPO-ONLINE SUBSCRIPTION
Lanzhou Foci Pharmaceutical Co., Ltd. has been approved by the China Securities Regulatory Commission (the CSRC) to issue 20.200000 million A-shares in its initial public offering.
1. Class: A shares
2. Stock code: 002644
3. Stock abbreviation: Foci Pharmaceutical
4. Issuing volume: 20.200000 million shares
5. Par value: CNY1.00 per share
6. Issuing mechanism: a book building process will be conducted with a combination of online public offering and offline placement.
7. Targeted listing bourse: Shenzhen Stock Exchange
8. Offline placement volume: 3.900000 million shares
9. Online offering volume: 16.300000 million shares
10. Price: CNY16.00 per share
11. Offline subscription period: 13 December 2011
12. Online subscription date: 13 December 2011.
Date: 2011-12-05
Title: IPO
Lanzhou Foci Pharmaceutical Co., Ltd. has been approved by the China Securities Regulatory Commission (the CSCR) to issue 20.2000 million A-shares in its initial public offering, which is structured as follows:
1.Class: A shares
2.Size: 20.2000 million shares
3.Par value: CNY1.00 per share
4.Issuing mechanism: a book building process will be conducted with a combination of online public offering and offline placement.
5.Targeted listing bourse: Shenzhen Stock Exchange
6.Offline placement volume: 3.9000 million shares
7.Online offering volume:16.3000 million shares
8.IPO price inquiry period: from 06 December 2011 to 08 December 2011
9.IPO price determined: 12 December 2011
10.Offline subscription date:13 December 2011
11.Online subscription date: 13 December 2011
12.Expected listing date:N/A.